Regarding: Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma

Affiliations

Comment

Shamar Young et al. Gastroenterology. 2017 May.

. 2017 May;152(6):1626-1627.

doi: 10.1053/j.gastro.2016.09.070. Epub 2017 Mar 31.

¹ University of Minnesota, Department of Radiology, Division of Interventional Radiology, Minneapolis, Minnesota.

No abstract available

Comment in

Reply.
Salem R, Lewandowski RJ. Salem R, et al. Gastroenterology. 2017 May;152(6):1628-1629. doi: 10.1053/j.gastro.2017.03.044. Epub 2017 Apr 1. Gastroenterology. 2017. PMID: 28376318 No abstract available.

Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, Mulcahy MF, Baker T, Abecassis M, Miller FH, Yaghmai V, Sato K, Desai K, Thornburg B, Benson AB, Rademaker A, Ganger D, Kulik L, Lewandowski RJ. Salem R, et al. Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27. Gastroenterology. 2016. PMID: 27575820 Free PMC article. Clinical Trial.